Partial reduction of blood pressure and prevention of complications in hypertension.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D008297:Male; D011446:Prospective Studies; D012110:Reserpine / Q000008:administration & dosage / Q000627:therapeutic use
D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D006830:Hydralazine; D012110:Reserpine